SOC TELEMED, INC. Financing Cash Flow
SOC TELEMED, INC. reported Financing Cash Flow of $134.26 million for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-31.
Discontinued › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2022-03-31
- SOC TELEMED, INC. net cash provided by (used in) financing activities for the quarter ending 2021-12-31 was $12.72M, a 73.80% decline year-over-year.
- SOC TELEMED, INC. net cash provided by (used in) financing activities for the quarter ending 2021-09-30 was -$271.00K, a 106.99% decline year-over-year.
- SOC TELEMED, INC. net cash provided by (used in) financing activities for the quarter ending 2021-06-30 was $27.09M, a 647.28% increase year-over-year.
- SOC TELEMED, INC. net cash provided by (used in) financing activities for the quarter ending 2021-03-31 was $94.72M, a 1203.23% increase year-over-year.
- SOC TELEMED, INC. net cash provided by (used in) financing activities for fiscal 2021 was $134.26M, a 112.04% increase from fiscal 2020.
- SOC TELEMED, INC. net cash provided by (used in) financing activities for fiscal 2020 was $63.32M, a 282.57% increase from fiscal 2019.
- SOC TELEMED, INC. net cash provided by (used in) financing activities for fiscal 2019 was $16.55M.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 12 month |
|---|---|---|---|---|
| 2021-12-31 | $12.72M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | $12.45M derived: sum of 2 quarters · filed 2022-03-31 | $39.54M derived: sum of 3 quarters · filed 2022-03-31 | $134.26M 10-K · filed 2022-03-31 |
| 2021-09-30 | -$271.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $26.82M derived: sum of 2 quarters · filed 2021-11-12 | $121.54M 10-Q · filed 2021-11-12 | $170.09M derived: sum of 4 quarters · filed 2022-03-31 |
| 2021-06-30 | $27.09M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $121.81M 10-Q · filed 2021-08-12 | $170.36M derived: sum of 3 quarters · filed 2022-03-31 | $174.23M derived: sum of 4 quarters · filed 2022-03-31 |
| 2021-03-31 | $94.72M 10-Q · filed 2021-05-17 | $143.27M derived: sum of 2 quarters · filed 2022-03-31 | $147.15M derived: sum of 3 quarters · filed 2022-03-31 | $150.77M derived: sum of 4 quarters · filed 2022-03-31 |
| 2020-12-31 | $48.55M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | $52.43M derived: sum of 2 quarters · filed 2022-03-31 | $56.05M derived: sum of 3 quarters · filed 2022-03-31 | $63.32M 10-K · filed 2022-03-31 |
| 2020-09-30 | $3.88M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $7.50M derived: sum of 2 quarters · filed 2021-11-12 | $14.77M 10-Q · filed 2021-11-12 | $266.19M derived: sum of 4 quarters · filed 2021-11-12 |
| 2020-06-30 | $3.63M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $10.89M 10-Q · filed 2021-08-12 | $262.31M derived: sum of 3 quarters · filed 2021-08-12 | |
| 2020-03-31 | $7.27M 10-Q · filed 2021-05-17 | $258.69M derived: sum of 2 quarters · filed 2021-05-17 | ||
| 2019-12-31 | $251.42M 10-K · filed 2020-03-25 | $16.55M 10-K · filed 2021-03-30 |